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Abstract
Background: Neisseria meningitidis serogroup B has been predominant in Brazil, but no broadly effective vaccine is available
to prevent endemic meningococcal disease. To understand genetic diversity among serogroup B strains in Brazil, we
selected a nationally representative sample of clinical disease isolates from 2004, and a temporally representative sample for
the state of Sa ˜o Paulo (1988–2006) for study (n=372).
Methods: We performed multi-locus sequence typing (MLST) and sequence analysis of five outer membrane protein (OMP)
genes, including novel vaccine targets fHbp and nadA.
Results: In 2004, strain B:4:P1.15,19 clonal complex ST-32/ET-5 (cc32) predominated throughout Brazil; regional variation in
MLST sequence type (ST), fetA, and porB was significant but diversity was limited for nadA and fHbp. Between 1988 and
1996, the Sa ˜o Paulo isolates shifted from clonal complex ST-41/44/Lineage 3 (cc41/44) to cc32. OMP variation was
associated with but not predicted by cc or ST. Overall, fHbp variant 1/subfamily B was present in 80% of isolates and showed
little diversity. The majority of nadA were similar to reference allele 1.
Conclusions: A predominant serogroup B lineage has circulated in Brazil for over a decade with significant regional and
temporal diversity in ST, fetA, and porB, but not in nadA and fHbp.
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Introduction
Neisseria meningitidis causes severe invasive disease which occurs
sporadically or as outbreaks and which is characterized by rapid
onset, high case fatality ratio and devastating sequelae. An
epidemic period of serogroup B meningococcal disease began
during the 1980’s with spread throughout Brazil [1]. The
incidence peaked in 1996 at 7.8 cases per 100,000 persons, and
the epicenter was Sa ˜o Paulo State, Brazil where 80% of cases were
caused by serogroup B strains [2]. Our aim was to describe
patterns of antigenic diversity geographically and over time in the
context of a predominantly clonal epidemic.
Polysaccharide and polysaccharide-protein conjugate vaccines
are effective and available for prevention of meningococcal
serogroups A, C, W-135, and Y, but not for serogroup B because
that capsule is poorly immunogenic. Outer membrane vesicle
vaccines have been used in epidemic situations [3] but vaccines to
prevent genetically diverse endemic serogroup B disease are
needed. Surface-exposed protein antigens are under investigation
as potential vaccine candidates; the most promising may be
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33016relatively conserved novel antigen targets identified through the
use of genomic and proteomic methods [4–6].
Serologic and molecular epidemiologic features of serogroup B
meningococcal disease have been described in individual regions
of Brazil [7–9], but nationally representative data have not been
analyzed since 1997–1998 [10]. Our goal was to determine the
genetic diversity of outer membrane proteins (OMPs) among a
representative sample of invasive serogroup B clinical isolates from
all major geographic regions of Brazil in 2004, and among
additional isolates from Sa ˜o Paulo from the years 1988, 1996, and
2006, which span the initiation, peak and decline of the most
recent epidemic at its epicenter [2]. To accomplish this, we
analyzed the sequence diversity of OMP genes porA, porB, fetA, and
the more recently identified genes fHbp and nadA encoding human
factor H binding protein (FHbp) and the invasin NadA [11–13].
We performed multilocus sequence typing (MLST) [14] and
examined associations between inferred OMP antigen type, strain
lineage, geographic region, and year.
Materials and Methods
Study population and selection of N. meningitidis isolates
In Brazil, isolates from patients with confirmed meningococcal
disease are reported through the Brazilian national meningitis
surveillance system. Clinical (date of onset, outcome) and
demographic (age, sex, region) information on suspected patients
with meningitis is routinely collected as part of this surveillance
system [2].
In 2004, 3,654 confirmed cases of meningococcal disease were
reported to the Brazilian Ministry of Health. Overall, 54.5% of
cases were reported from the Southeast, with the remainder
reported from the other regions as follows: Northeast, 19.8%;
South, 15.8%; North, 6.8%; Center-West, 3.1%. Serogroup was
identified for 33% (1,222/3,654), of which 52% (n=639) were
serogroup B and were considered for this study. Demographic and
clinical information for patients with isolates and serogroup
information was similar to those without serogroup information.
The anonymized samples analyzed in this study were a subset of
all Brazilian group B N. meningitidis isolates received and stored by
the National Reference Laboratory, Instituto Adolfo Lutz (IAL),
for the year 2004. To ensure both a sufficient sample size and
proportional representation within regions, only states with 10 or
more serogroup B isolates during 2004 were included (Center-
West region excluded), and 50% of isolates from each of these
states were selected through a convenience sample, using stored
samples with sufficient quantity and quality for analysis. The
regional representation of selected samples was as follows: South,
n=47 (20%); Southeast, n=92 (39.1%); North, n=21 (9.0%);
Northeast, n=75 (31.9%).
For the temporal analysis of meningococcal disease in Sa ˜o
Paulo, a convenience sample of isolates from three additional years
representing different phases of the epidemic period were selected:
50 isolates from 1988, 50 from 1996 and 47 from 2006. Seventy-
one isolates from the 2004 sample were from the Sa ˜o Paulo region
and were also included in the temporal analysis.
PCR amplification, primer design and sequencing
strategy
Heat killed cells were sent from IAL to CBER FDA where
purified genomic DNA was extracted using QiagenH DNeasy
Blood & Tissue Kit. Primers for PCR were modified from those
previously described for MLST [14], porA [15], porB [16] and fetA
[17] and were developed for fhbp variant 1 and nadA (Appendix 1).
PCR primers were 59-tagged with M13 forward and reverse
oligonucleotides which were used as anchors for subsequent high
throughput sequencing. Internal untagged sequencing primers
were used for porA, porB, fetA, and nadA (Table S1). Each locus was
amplified with 0.5 uM of each primer using QiagenH HotStar
HiFidelity (Qiagen, Valencia, CA, USA). Sequencing was
conducted at the J. Craig Venter Institute (JCVI) on an ABIH
3770 automatic sequencer using ABIH BigDye terminator V. 3.2.
in duplicate for each primer, resulting in an average of 46
coverage for MLST genes and fHbp and an average of 86
coverage for the remaining OMP genes. Amplification and
sequencing was repeated for incomplete amplification and/or
sequencing failures including amplification with non-tagged
primers where needed.
Sequence assembly and editing
Sequences were assembled with the TIGR assembler [18] and
examined for at leastdouble coverage, edited, and curated using Cloe
(a multiple sequence editor heavily integrated with the TIGR
database). Manual editing was used to resolve ambiguous bases,
evaluate quality of 16 areas, extend or join contigs, and confirm
novel sequence types (STs), rare SNPs and frameshifts. Alignments
were generated using CLUSTALW [19] and locally developed Perl
and shell scripts, manually curated in Bioedit [20], and trimmed in-
frame internal to the primer sequences. Each contig had no
ambiguous bases, 36or greater average sequence coverage (direction
independent) and/or manual inspection and confirmation of high
quality 16regions. Four thousand one hundred and forty-six or 90%
of the targets were submitted to GenBank with accession numbers as
follows: abcZ: GQ169817-GQ170194; adk: GQ170195-GQ170569,
GU245934; aro: GQ170570-GQ170942, GU245933; fumC:
GQ171288-GQ171658, GU245932; gdh: GQ171659-GQ172036,
GU245931; pdhC: GQ172956-GQ173322, GU245928; pgm:
GQ173323-GQ173644, GU245927; porA: GQ173645-GQ173953;
porB: GQ173954-GQ174287; fetA: GQ170943-GQ171287; fHbp:
GQ172370-GQ172679, GU245930; nadA: GQ172680-GQ172955,
GU245929.
Clonal complex (cc), ST and genotype determination
cc and ST were determined through the publicly available
Neisseria Multilocus Sequence Typing (MLST) website (http://
pubmlst.org/ neisseria/) maintained at the University of Oxford,
UK [21] based on the MLST method described by Maiden et al
[14]. Sequence-based ‘‘antigen’’ types were assigned from inferred
protein sequences for PorA variable region (VR)1, VR2, and VR3
(loops I, IV and V); PorB loops I, IV, V, VI, and VII; FetA allele
and FHbp variable segments A, B, C and D. New STs and new
OMP sequences for porA, porB and fetA were deposited in the
Neisseria database [21].
Data analysis
To identify associations of demographic characteristics with
antigen types, cc, and ST, we compared the proportion of variants
by patient age, sex, and geographic region for 2004 samples, and
by patient age, sex and year of collection for Sa ˜o Paulo samples
using SAS (v9.2). Statistical significance was assessed using the chi-
squared test, with p#0.05.
Phylogenetic relationships among meningococcal isolates were
inferred from concatenated MLST gene DNA sequences using
maximum likelihood methods. Sequences were aligned using the
MUSCLE program [22]. Concatenated MLST sequences were
analyzed for recombination using ClonalFrame v1.2 [23].
Maximum likelihood phylogenies were calculated using Garli
v0.96 [24] for sample subsets specific for 2004 and Sa ˜o Paulo. A
Neisseria meningitidis Serogroup B in Brazil
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sequences combined due to the low degree of diversity observed.
For nadA, phylogenetic analysis of translated amino acid was
conducted using the heuristic maximum parsimony algorithm of
PAUP 4b10 [25] so that information about internal gaps could be
used for phylogenetic inference. For the purpose of allele
classification, the multiple sequence alignment included three
NadA exemplar sequences for alleles 1, 2, and 3 [26].
This study was approved by the scientific and ethical
committees of the IAL, Sa ˜o Paulo, Brazil and exempted from
NIH IRB review by the NIH Office for Human Subjects Research
(OHSR).
Results
Study population
Overall, 374 of the 382 isolates initially obtained could be
processed and had sufficient sequence data for allele assignment
for at least one MLST or OMP gene. MLST cc, based on
minimum of four MLST gene sequences, was assigned using the
Neisseria database (http://pubmlst.org/neisseria/) [21] for 354
isolates (95%), of which of 343 (96.9%) belonged to one of 6
hypervirulent clonal complexes: ST-32/ET-5 (cc32), ST-41/44
(cc41/44), ST-11/ET-37 (cc11), ST-23/A3 (cc23), ST-8/A4 (cc8),
ST-269 (cc269). A total of 283 (75.7%) isolates with seven
complete MLST gene sequences were assigned an MLST ST.
Sixty-seven (23.7%) of those had one of 62 new STs not previously
reported; an additional 19 had an ST not previously reported from
Brazil. For 2004 data, the proportion with missing cc, ST or OMP
sequences did not vary significantly by region. With respect to
year, fetA had significantly more missing data for 1988 and 2006
samples (16% and 13% respectively), and porA had a significantly
higher proportion missing for 1988 compared with other years.
With respect to the OMP genes, the number of samples with
sequence data sufficient to assign a type through the neisseria
database were: PorB (5 loops: I, IV, V, VI, VII), 302 (81%); PorA
(VR1, VR2 and VR3), 302 (81%); FetA, 334 (89%); fHbp
(segments A, B,C, D), 262 (70%). Evaluable sequences for NadA
were obtained from 272 (73%).
The predominant European Monitoring Group for Meningo-
cocci (EMGM) types [27] among 231 isolates with data for PorA,
FetA, and ST were as follows: B: P1.19,15: F5-1: ST-33 (cc32)
(24%), followed by B: P1.19,15: F5-1: ST-34 (cc32) (10.8%) and B:
P1.19,15: F5-1: ST-639 (cc32) (10.4%). Other variants of the same
PorA, FetA, and cc32 but with different STs comprised an
additional 9.1%.
Geographic diversity of N. meningitidis: 2004 isolates
Patient age and sex for isolates was representative of meningitis
cases in Brazil for 2004; 29% (n=59) of isolates were from
children aged #2 years. Overall, eight distinct cc were identified:
189 (86.3%) isolates were cc32, 17 (7.8%) were cc41/44, and the
remaining 11 were cc 23 (n=2), cc11 (n=2), cc35 (n=3), cc461
(n=2), cc175 (n=1), and cc269 (n=1). The predominant cc in all
regions was cc32 (Figure 1a). No significant differences in cc
distribution by age group or region were identified.
Sixty-one STs were identified among 2004 isolates, but three
STs of cc32 accounted for 55.9%: ST-33 (n=46; 26.1%), ST-34
(n=26; 14.7%), and ST-639 (n=27; 15.3%). Unlike cc, the
pattern of ST distribution among 2004 isolates did vary by region.
In the North, ST-5996 predominated (7/13, 54%) and no isolates
of ST-639 were identified. In contrast, ST-639 was common in the
other regions, ranging from 10–20% of isolates. In the Northeast
region, ST-33 predominated, comprising 40% of isolates while in
the South and Southeast, the proportion of ST-33 (17%–20%) and
ST-34 (22%-20%) were similar. Thirty-two new STs were
identified among 33 strains; new STs were identified in all regions
and distributed evenly across age groups.
fetA and porB also had a significantly different distribution of
alleles across geographic regions. FetA 5-1 predominated in all
regions except the North where 52.9% were 5–13 (Table 1). PorB
loop sequence type 4,7,11,9,5 was present in 70–79% of isolates in
the North and Northeast, whereas in the South and Southeast a
greater number of different PorB were observed and only 55%–
59% of isolates had the same predominant inferred PorB type
(Table 1).
OMP type was significantly associated with cc. Among cc32
isolates, 63% were inferred PorB type 4,7,11,9,5; 73% were PorA
type 19,15,36 and 68.8% were FetA type 5-1. In contrast, within
the cc41/44, only 1 (7.1%) was PorB type 4,7,11,9,5, none were
PorA type 19,15,36 and none were Fet-A type 5-1. The most
common 2004 type based on the European Monitoring Group for
Meningococci (EMGM) classification system was B: P1.19,15: F5-
1: ST-33 (cc32) (25.8%), followed by B: P1.19,15: F5-1: ST-34
(cc32) (17.7%), and B: 19,15: F:5-1: ST-639 (cc32) (9.7%), with the
remainder comprising a variety of other types.
Analysis of the concatenated MLST sequences by ClonalFrame
found evidence of limited recombination within individual MLST
loci. Examination of the sequences found that these events were
over small tracts of sequence and limited to at most one event. For
these reasons recombination within MLST loci did not overwhelm
the phylogenetic signal in the sequences, as demonstrated by the
Figure 1. Distribution of clonal complexes by year and region
in Brazil. 1a. Clonal complex by Region, Brazil 2004. 1b. Clonal complex
by year, Sa ˜o Paulo, Brazil, 1988–2004. Footnote for Fig. 1a and 1b:
*Other Hypervirulent (HV) cc=ST-8/A4, ST-23/A3; ST-11/ET-37. **Non-
HV cc=ST-461,ST-103,ST-175,ST-254,ST-269,ST-35,ST-5/III; also includes
STs that did not group with any known clonal complex (‘‘unassigned’’).
doi:10.1371/journal.pone.0033016.g001
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analysis.
By phylogenetic analysis of concatenated MLST genes for 2004,
neither the cc41/44 nor the cc32 clades were completely
monophyletic. The region in which the isolates were collected
did not correspond with the underlying MLST phylogenetic
structure (Figure 2). While the cc32 clade had low diversity in
OMP type overall, appreciable variability was observed. Notably,
variability in one OMP was not predictive of diversity in other
OMPs or MLST clade. Overall, the predominantly cc41/44 clade
was more diverse in associated OMP types than the predominantly
cc32 clade.
Temporal diversity of N. meningitidis: Sa ˜o Paulo isolates
Among Sao Paolo isolates from 1988, 1996, 2004 and 2006,
patient age (n=175) and sex (n=214) distributions did not vary
significantly by year; and were representative of reported
meningococcal disease in those years. The 111 cc32 strains were
primarily ST-33 (n=47, 42%), ST-34 (n=12, 10.8%), and ST-
639 (n=26, 23.4%). Both cc and ST distribution varied
significantly by year of isolation: the proportion of cc32 increased
from 44.7% in 1988 to 73.5% in 1996, and to 84.1% in 2004,
(Figure 1b). Within cc32, the ST distribution changed significantly,
particularly after 1996, with a decrease in ST-33, and an increase
in other STs, particularly ST-34 and ST-639, and an increase in
unique STs from 1996 to 2004 and 2006. Among the Sa ˜o Paulo
isolates, PorA, PorB, and FetA antigen types varied significantly
over time (Table 2).
By phylogenetic analysis of concatenated MLST genes of the
Sa ˜o Paulo samples, the year of collection did not correspond to the
branching structure of the tree (Figure 3) and the dominant STs
were found in all years. As with 2004 isolates, the Sa ˜o Paulo OMP
diversity was low overall within the cc32 clade and the diversity
observed did not correspond to phylogenetic structure, year of
isolation or other OMP type.
Sequence diversity of fHbp and nadA among Brazilian
group B isolates
fHbp variant 1 genes were sequenced from 306 isolates (80%) and
256 (83.7%) of these were identical throughout their length to the
pubMLST.org/Neisseria fHbp allele 311 (B24, variant 1.1, or
segments A1-2, B1-1, C1.5 and D1.5.). Twenty sequences matched
one of 10 other alleles available in the database, and 30 sequences
had one of 20 new alleles not previously reported. A maximum-
likelihood tree for 250 sequences (sequences with leading or trailing
gaps were removed from the analysis) was determined using Garli
v0.96 [24] (Figure 4). One large clade corresponded to allele 311
while the other major group was more variable (19 alleles among 33
samples) and contained within it one group of 4 identical sequences
that were very different from the other sequences (segments A2-3,
Table 1. PorA, PorB, FetA, FHbp by Region, 2004.
N
n( % )
NE
n( % )
S
n( % )
SE
n (%) Total
PorA
(VRI, VR2, VR3)
n( % )
19, 15, 36 12 (70.6) 44 (73.3) 25 (78.1) 54 (69.2) 135 (72.2)
7-1, 1, 35-1 0 8 (13.3) 0 8 (10.3) 16 (8.6)
7, 16, 35 1 (5.8) 0 4 (12.5) 0 5 (2.7)
Other 1 (5.8) 8 (13.3) 3 (9.4) 16 (20.5) 31 (16.6)
Total 17 60 32 78 187
PorB*
(Loops I, IV, V, VI, VII)
4,7,11,9,5 15 (79.0) 42 (70.0) 20 (58.8) 42 (55.3) 119 (63.0)
4,7,31,9,5 0 7 (11.7) 0 10 (13.2) 17 (9.0)
3,7,12,11,9 0 2 (3.3) 2 (5.9) 2 (2.6) 6 (3.2)
7,7,10,12,11 0 0 6 (17.7) 1 (1.3) 7 (3.7)
9,7,13,9,12 2 (10.5) 1 (1.7) 1 (2.9) 3 (4.0) 7 (3.7)
Other 2 (10.5) 8 (13.3) 5 (14.7) 18 (23.7) 33 (17.5)
Total 19 60 34 76 189
FetA* allele
5-1 2 (11.7) 51 (78.5) 24 (66.7) 61 (72.6) 138 (68.3)
5-13 9 (52.9) 1 (1.5) 0 1 (1.2) 11 (5.4)
3-4 2 (11.8) 0 0 0 2 (1.0)
Other 4 13 12 22 51 (25.2)
Total 17 65 36 84 202
FHbp Segments
A1-2, B1-1, C1-5, D1-5
17 (100) 39 (84.8) 31 (86.1) 56 (91.8) 143 (86.7)
Other 0 7 (15.2) 5 (13.9) 5 (8.2) 14 (13.3)
Total 17 46 36 61 157
*p,0.05 for differences across regions.
doi:10.1371/journal.pone.0033016.t001
Neisseria meningitidis Serogroup B in Brazil
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33016Neisseria meningitidis Serogroup B in Brazil
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33016B1-1, C1-4, and D1-1). These four identical fHbp sequences had
three different CC assignments (cc32, cc41/44, and cc269), were
collected in three different years (1988, 2004, and 2006) and from
three different regions (NE, S, and SE). In contrast to concatenated
MLST sequences, ClonalFrame analysis of fHbp sequences
identified greater evidence of recombination. The fHbp consensus
tree had very little deep structure and the relationships between
clades were unresolved indicating that the phylogenetic signal was
obscured by recombination. For the fHbp sequences, the region
estimated to have undergone recombination was approximately
33% of the total sequence.
The large majority of Brazilian nadA sequences (93%, 254/272)
were identical to the allele 1 reference sequence (GenBank
AF452481) and an additional 4% (n=12) were highly similar but
had single nucleotide insertions that resulted in early termination
(n=9) or an in-frame insertion or subtitution (n=3). Of the six
remaining sequences, one was identical to allele 3, and five were
similar to either reference allele 2 or 3 but were mosaic with
features showing evidence of horizontal exchange.
Discussion
In this paper we present the first nationally representative
genetic study of serogroup B N. meningitidis in Brazil since 1998,
and the first report from Brazil that examines genetic lineages in
combination with an analysis of genetic diversity among 5 OMP
genes: porA, porB, fetA, fHbp, and nadA. We also present an historic
comparison of group B strains from Sa ˜o Paulo for four time points
spanning 18 years (1988–2006).
Previous regional reports have described a predominant
Brazilian cc32 strain with phenotype, B: 4,7; P1.19,15 [1,2,7–
9,28]. A large proportion of isolates in our study had correspond-
ing OMP sequence types: PorB loop I-4 (serotype 4) and loop VI-9
or VI-24 (serotype 7) [29], PorA VR 1–19 and VR 2–15
(serosubtype PI.19,15). However, regional differences in diversity
of STs and OMPs were observed. In particular, the highest
proportion of non-dominant PorA and PorB sequence types were
identified in isolates from the Southeast region, and isolates from
the North had a strikingly different distribution of FetA and ST.
Figure 2. Maximum-likelihood phylogeny of the MLST DNA sequences from 2004. Annotations are for OMP types as defined by the
neisseria.org (http://pubmlst.org/ neisseria.org/) (PorA, PorB, FetA, and FHbp, respectively), clonal complex, and region of collection. Numbers above
the branches are bootstrap percentages.
doi:10.1371/journal.pone.0033016.g002
Table 2. Por A, Por B, FetA, FHbp by Year, Sao Paolo.
1988 1996 2004 2006 Total
PorA*
(VRI, VR2, VR3)
n( % )
19,15,36 6 (22.2) 33 (70.2) 42 (70) 19 (52.8) 100 (58.8)
18-7, 9, 35-1 9 (33.3) 2 (4.3) 1 (1.7) 2 (5.5) 14 (8.2)
7-1, 1, 35-1 2 (0.62) 2 ( 4.3) 5 (8.3) 2 (5.5) 11 (6.5)
7-2, 13-1, 35-1 2 (0.62) 1 (2.1) 0 2 (5.5) 5 (2.9)
22-1, 14, 38 1 (0.37) 0 1 (1.7) 3 (8.3) 5 (2.9)
Other 16 (59.3) 9 (19.1) 11 (18.3) 8 (22,.2) 34 (20.0)
Total 27 47 60 36 170
PorB*
(Loops I, IV, V, VI, VII)
4,7, 11, 9, 5 11 (34.4) 31 (73.8) 30 (52.6) 21 (55.3) 93 (55.0)
4,7, 11, 6, 5 9 (28.1) 1 (2.4) 1 (1.8) 2 (5.3) 13 (7.7)
4,7, 31, 9, 5 1 (3.1) 1 (2.4) 6 (10.5) 3 (7.9) 11 (6.5)
4, 5, 7, 9, 5 3 (9.4) 1 (2.4) 2 (3.5) 1 (2.6) 7 (3.9)
3,7,12, 11,9 3 (9.4) 1 (2.4) 2 (3.5) 3 (7.9) 9 (5.1)
Other 5 (15.6) 7 (16.7) 16 (28.1) 8 (21.1) 36 (20.2)
Total 32 42 57 38 169
FetA allele
5-1 14 (34.2) 35 (71.4) 47 (71.2) 21 (51.2) 104 (56.5)
4-1 10 (24.4) 2 (4.1) 1 (1.5) 1 (2.4) 14 (7.6)
Other 17 (41.4) 12 (24.5) 18 (27.3) 19 (46.4) 66 (35.8)
Total 41 49 66 41 184
FHbp Segments
A1-2, B1-1, C1-5, D1-5
28 (87.5) 31 (96.9) 43 (93.5) 21 (75) 123 (89.1)
Other 4 (12.5) 1 (3.1) 3 (6.5) 7 (25) 15 (10.9)
Total 32 32 46 28 138
*p,0.05 for differences across years.
doi:10.1371/journal.pone.0033016.t002
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33016The observed regional differences, with different patterns in the
North, may be because the North is remote and sparsely populated
relative to the other regions, with fewer introductions and less
circulation of introduced strains. The North has a population
density of 3.35 inhabitants/km
2 compared with a density of 30.7
for the Northeast and 78.2 for the Southern region [30].
Previous studies have demonstrated that a limited repertoire of
antigen variants persist over time and tend to be associated with
particular invasive clones [31,32]. However, because of horizontal
gene transfer, the associations are not absolute, and therefore OMP
genotype cannot be inferred from cc or ST. The strong associations
between FetA, PorA and PorB types within cc32, both over time and
acrossgeographicregions,areconsistentwiththeseearlierstudiesand
the significant decrease in ST-33 and increase in unique STs after
1996 shows diversification of the epidemic clone over time. Distinct
differences in OMP types and an overall greater degree of OMP
diversity were observed in cc41/44 isolates relative to cc32 by
categorical and phylogenetic analysis for both 2004 and Sa ˜o Paulo.
FHbp and NadA are under investigation as novel vaccine
candidates [33–35] making characterization of genetic diversity
relevant to estimations of vaccine coverage [36–38]. FHbp has been
found in the majority of meningococcal strains regardless of
serogroup, clonal lineage or disease/carrier origin. Recent studies in
the US, Europe and South Africa [38,39], showed that 65% to 77% of
strains are variant 1 fHbp. In our analysis of Brazilian serogroup B
meningococcal disease isolates, at least 80% of isolates had variant 1/
subfamily B fHbp genes, and the large majority were identical to allele
311 (variant 1.1 or B24). Based on the modular nomenclature of Pajon
[40], all variant 1 fHbp were modular group I with the exception of 4
allele 15 genes belonging to modular group IV. Geographic
differences in the frequencies of modular groups have been reported,
for example group IV was more frequent in the UK (23% of all
isolates) than in the US (,1%) or France (6%). Strains with fHbp
belonging to modular group IV in the UK may be associated with
ccST-269, a new hypervirulent clonal complex causing disease in
several European countries [41]. Based on our data, fHbp variant 1 is
predominant among Brazilian serogroup B N. meningitidis, but the
emergence of modular group IV should be monitored.
nadA wasalsoveryhomogeneousintheBraziliangroupBisolates.
Only two nadA sequences clustered with allele 3 and nadA from four
isolates were similar to allele 2 having a characteristic 7AA deletion
and lacking the 47AA deletion of allele 1. Five of the six nadA allele 2
or 3 isolates were from recent years (2004–2006) in the S and SE
regions. The remaining nadA were all identical or similar to allele 1.
Identification of nadA has been reported in approximately 50% of
disease-associated N. meningitidis overall, and 100% of strains
belonging to the hypervirulent lineages cc32, cc11 and cc8, but in
only 16% of carriage isolates [26]. The nadA gene has not been
previouslydetected incc41/44isolates.However,weidentifiednadA
from several cc not previously described including cc41/44 (among
three new STs), cc23, and isolates of five new STs belonging to non-
hypervirulent lineages. NadA expression was not studied here, but
evidence of premature stop codons and variation in the TAAA
repeat region preceding the start codon (data not shown) were
observed. Accurate assessment of protein expression will be an
essential aspect of future studies undertaken to evaluate NadA or
other OMPs as vaccine targets.
We found substantially lower genetic diversity of fHbp and nadA
compared to other OMPs, even correcting for the predominance
of the cc32 epidemic strain. The reasons for the lower diversity
among these OMP remain unclear. Diversity may be functionally
limited in the context of human disease, which would support the
hypothesis that they will be broadly protective as vaccine targets.
Alternatively, there may be less immunologic pressure to diversify
for these proteins than for the major OMPs in the context of the
human host environment (predominantly carriage), either because
of lower expression density on the surface, or because of
alternative mechanisms of escape such as down regulation. Some
diversity is clearly tolerated, and from our sequence analysis,
horizontal genetic exchange plays a similar role as with other
neisserial OMPs. Further study of the diversity of these novel
proteins and the potential coverage of new vaccines is needed.
In summary, our study provides a comprehensive molecular
analysis of ST and OMP genetic diversity of Brazilian group B
meningococcal isolates. In 2004, group B meningococcal disease
was predominantly caused by cc32 strains; cc and OMP type were
strongly associated, but OMP diversity was not uniformly
predicted by cc or other OMP type among either the geographic
or the temporal samples. cc41/44 showed greater ST and OMP
diversity which may be the result of an older evolutionary origin.
fHbp and nadA sequences were highly homogeneous within the
population of disease isolates examined. Although N. meningitidis
serogroup C disease has increased since 2006, serogroup B
continues to be a significant cause of meningococcal disease in
Brazil and will remain so even if widespread use of conjugate
vaccines is implemented. Greater understanding of the mecha-
nisms of genetic diversification of serogroup B N. meningitidis is
important for successful development, introduction, and long-term
use of vaccines intended to prevent serogroup B disease.
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